Clinical Trial Update: A Controlled Study of Solriamfetol for Attention Deficit Hyperactivity Disorder (ADHD) in Adults [Phase 2, Phase 3]

View source ↗

Summary

A controlled study of solriamfetol for ADHD in adults across Phase 2 and Phase 3 has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Solriamfetol (solriamfetol)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Attention Deficit Hyperactivity Disorder | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2024-03-04